Stay updated on Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.

Latest updates to the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page
- Check6 days agoChange DetectedThe page adds a recruitment notice 'No longer looking for participants' and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting update to the Intervention/Treatment heading, and the site revision is updated to v3.6.0.SummaryDifference0.4%

- Check13 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, reflecting a minor page system update. It does not change the study data, eligibility criteria, or results on the page, only the page's revision label.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page displays Revision: v3.5.4, replacing the previous v3.5.3, indicating a small update to the page template or site components.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.5.3 was added and Revision: v3.5.2 was removed from the revision history, representing a minor update to the site's version record.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded informational resource/topic links for **Idiopathic Pulmonary Fibrosis** and the **Genetic and Rare Diseases Information Center**.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No user-facing content or study information was changed.SummaryDifference0.0%

Stay in the know with updates to Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.